Form 4 for INSM INSMED Inc
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-12 · accession 0001628280-24-051195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $72.98 | -6,830 | 236.7K | -3% | -$498.5K |
| DM | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $72.97 | -18.8K | 385.0K | -5% | -$1.37M |
| D | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 403.7K | +5% | +$426.8K |
| DI | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| D | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -18.8K | 131.2K | -12% | $0 |
| DI | 2024-12-13 | 2024-12-12 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -6,830 | 239.1K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-12 | S | D | 2,562 | $73.55 | 234,105 | I | — | — | (F7) This is the weighted average sales price representing 2,562 shares sold at prices ranging from $73.16 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2024-12-12 | S | D | 181 | $74.22 | 233,924 | I | — | — | (F8) This is the weighted average sales price representing 181 shares sold at prices ranging from $74.20 to $74.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2024-12-12 | S | D | 6,847 | $73.56 | 385,359 | D By the Katie Procter Dynasty Trust | — | — | (F4) This is the weighted average sales price representing 6,847 shares sold at prices ranging from $73.16 to $74.14 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2024-12-12 | S | D | 11,504 | $72.58 | 392,206 | D By the Katie Procter Dynasty Trust | — | — | (F3) This is the weighted average sales price representing 11,504 shares sold at prices ranging from $72.05 to $73.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2024-12-12 | S | D | 399 | $74.23 | 384,960 | D By the Katie Procter Dynasty Trust | — | — | (F5) This is the weighted average sales price representing 399 shares sold at prices ranging from $74.18 to $74.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Common | Common Stock | 2024-12-12 | S | D | 4,087 | $72.57 | 236,667 | I | — | — | (F6) This is the weighted average sales price representing 4,087 shares sold at prices ranging from $72.05 to $73.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Common | Common Stock | 2024-12-12 | M | A | 18,750 | $22.76 | 403,710 | D By the Katie Procter Dynasty Trust | — | — | (F2) Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan. |
| 8 | Common | Common Stock | 2024-12-12 | M | A | 6,830 | $10.85 | 240,754 | I | — | — | |
| 9 | Derivative | Stock Option (right to buy) | 2024-12-12 | M | D | 18,750 | $0.00 | 131,250 | D By the Katie Procter Dynasty Trust | $22.76 · — to 2025-05-21 | 18,750 Common Stock | (F9) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 10 | Derivative | Stock Option (right to buy) | 2024-12-12 | M | D | 6,830 | $0.00 | 239,120 | I | $10.85 · — to 2026-05-19 | 6,830 Common Stock | (F9) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |